Sionna Therapeutics Share Price Today: Live Updates & Key Insights
Sionna Therapeutics share price today is $36.45, up 2.54%. The stock opened at $35.32 against the previous close of $35.49, with an intraday high of $37.37 and low of $35.32.
Sionna Therapeutics Share Price Chart
Sionna Therapeutics
Sionna Therapeutics Share Price Performance
Sionna Therapeutics Institutional Holdings
Sionna Therapeutics Market Status
Sionna Therapeutics Fundamentals
Market Cap 1637.48 M
PB Ratio 5.3367
PE Ratio 0.0
Enterprise Value 1410.27 M
Total Assets 325.95 M
Volume 339158
Sionna Therapeutics Company Financials
About Sionna Therapeutics & investment objective
Company Information Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF). It develops galicaftor (SION-2222), a transmembrane domain 1 (TMD1)-directed cystic fibrosis transmembrane conductance regulator (CFTR) that has completed Phase 2 trial; navocaftor (SION-3067), a potentiator that has completed Phase 2 trial; SION-109, an intracellular loop 4 directed CFTR corrector that has completed Phase 1 trial; SION-2851, a TMD1-directed CFTR corrector that has completed Phase 1 trial; SION-451, which is nucleotide-binding domain 1 stabilizer in Phase 1 trial; and SION-719, which is nucleotide-binding domain 1 stabilizer in Phase 2a proof-of-concept trial. The company was formerly known as Sling Therapeutics, Inc. and changed its name to Sionna Therapeutics, Inc. in July 2021. Sionna Therapeutics, Inc. was incorporated in 2019 and is headquartered in Waltham, Massachusetts.
Organisation Biotechnology
Employees 59
Industry Biotechnology
CEO Mr. Michael Cloonan M.B.A.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Sionna Therapeutics FAQs
What is the share price of Sionna Therapeutics today?
The current share price of Sionna Therapeutics is $36.45.
Can I buy Sionna Therapeutics shares in India?
Yes, Indian investors can buy Sionna Therapeutics shares by opening an international trading and demat account with Motilal Oswal.
How to buy Sionna Therapeutics shares in India?
You can easily invest in Sionna Therapeutics shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Sionna Therapeutics shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Sionna Therapeutics.
Can I buy fractional shares of Sionna Therapeutics?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Sionna Therapeutics?
Sionna Therapeutics has a market cap of $1637.48 M.
In which sector does Sionna Therapeutics belong?
Sionna Therapeutics operates in the Biotechnology sector.
What documents are required to invest in Sionna Therapeutics stocks?
To invest, you typically need:
What is the PE and PB ratio of Sionna Therapeutics?
The PE ratio of Sionna Therapeutics is N/A and the PB ratio is 5.34.